Fresenius Medical Care Recalls Sanxin Single-Use Syringes for Leakages

November 16th, 2023|

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Device Use The Fresenius Medical Care Sanxin Single Use Sterile Syringes are used during hemodialysis treatments. They are used to draw heparin, a blood thinning medicine used to prevent blood clots.

Do Not Use Certain Brands of Saline and Sterile Water Medical Products by Nurse Assist Because They May Not Be Sterile

November 7th, 2023|

The U.S. Food and Drug Administration (FDA) is warning consumers, health care providers, and health care facilities not to use recalled saline (0.9% sodium chloride) and sterile water medical products manufactured by Nurse Assist, LLC, and sold under various brands. On November 6, 2023, Nurse Assist, LLC announced a recall of the following water-based medical

Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall

October 30th, 2023|

Exela Pharma Sciences, LLC, (Exela) is voluntarily recalling the products listed in the link below to the consumer level. Particulate matter identified as silicone was observed during routine inspection of retain samples. Risk Statement Administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign

NEW CDC Toolkits to Prepare for Flu, COVID-19, and RSV

October 30th, 2023|

CDC recently released a new Resources to Prepare for Flu, COVID-19, and RSVwebpage which provides toolkits and resources for various communities on preparing for the flu, COVID-19, and respiratory syncytial virus (RSV) during the fall/winter season.

Novartis Issues Voluntary Nationwide Recall of One Lot of Sandimmune® Oral Solution Due to Crystallization

September 13th, 2023|

Novartis is conducting a voluntary nationwide recall at the consumer level of one lot of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. No other Sandimmune formulations are impacted. Sandimmune® Oral Solution (cyclosporine oral solution,

CDC Health Advisory: Increased RSV Activity

September 7th, 2023|

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and caregivers about increases in respiratory syncytial virus (RSV) activity across some parts of the Southeastern United States in recent weeks, suggesting a continued shift toward seasonal RSV trends observed prior to the COVID-19 pandemic.

FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults

May 26th, 2023|

Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death. Paxlovid is the fourth drug—and first oral antiviral pill—approved by the FDA

All Opioid Pain Medicines: FDA Updates Prescribing Information

April 17th, 2023|

Issue The U.S. Food & Drug Administration (FDA) is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for all opioid pain that the risk of overdose increases as the dose increases. The updates to IR opioids state these products should not be used for